ConductScience.org, home

Paper42978552PubMed

Comparative outcomes of adjuvant treatment approaches in resected stage I-III gastric cancer.

Yildiz B and 3 others. Front Oncol, 2026.

Cite this record

ConductScience Library. Comparative outcomes of adjuvant treatment approaches in resected stage I-III gastric cancer. Papers, record 42978552. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42978552

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Comparative outcomes of adjuvant treatment approaches in resected stage I-III gastric cancer.
Journal
Front Oncol
Year
2026
Publication types
Journal Article
Revised in PubMed
2026-11-05

Source PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yildiz BBulent
2Karateke YSYasemin Sagdic
3Garbioglu DBDuygu Bayir
4Demir MMetin

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References38

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129609047Lymphovascular invasion as a predictor for lymph node metastasis and a prognostic factor in gastric cancer patients under 70 years of age: A retrospective analysis.Int J Surg2018https://conductscience.org/library/papers/29609047PubMed
217440161Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.J Natl Cancer Inst2007https://conductscience.org/library/papers/17440161PubMed
327697982Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw2016https://conductscience.org/library/papers/27697982PubMed
439023597Adjuvant Concurrent Chemoradiotherapy (CRT) plus Docetaxel-Cisplatin-Fluorouracil (DCF) versus CRT plus Fluorouracil-Folinic Acid (FUFA) in Stage III Gastric Cancer.J Cancer Res Ther2024https://conductscience.org/library/papers/39023597PubMed
525223244Impact of extranodal extension on prognosis in lymph node-positive gastric cancer.Br J Surg2014https://conductscience.org/library/papers/25223244PubMed
629450755Efficacy of Adjuvant S-1 Versus XELOX Chemotherapy for Patients with Gastric Cancer After D2 Lymph Node Dissection: A Retrospective, Multi-Center Observational Study.Ann Surg Oncol2018https://conductscience.org/library/papers/29450755PubMed
725759484Prognostic significance of the concomitant existence of lymphovascular and perineural invasion in locally advanced gastric cancer patients who underwent curative gastrectomy and adjuvant chemotherapy.Jpn J Clin Oncol2015https://conductscience.org/library/papers/25759484PubMed
822184384
Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial.
J Clin Oncol2012https://conductscience.org/library/papers/22184384PubMed
910450730Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group.Ann Surg1999https://conductscience.org/library/papers/10450730PubMed
1015082726Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial.J Clin Oncol2004https://conductscience.org/library/papers/15082726PubMed
1121414740Prospective, randomized trial comparing 5-FU/LV with or without oxaliplatin as adjuvant treatment following curative resection of gastric adenocarcinoma.Eur J Surg Oncol2011https://conductscience.org/library/papers/21414740PubMed
1222226517Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial.Lancet2012https://conductscience.org/library/papers/22226517PubMed
1327664260Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Ann Oncol2016https://conductscience.org/library/papers/27664260PubMed
1427342689Japanese gastric cancer treatment guidelines 2014 (ver. 4).Gastric Cancer2017https://conductscience.org/library/papers/27342689PubMed
1527412320Extranodal Extension of Nodal Metastases Is a Poor Prognostic Indicator in Gastric Cancer: a Systematic Review and Meta-analysis.J Gastrointest Surg2016https://conductscience.org/library/papers/27412320PubMed
1625559811
Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses.
J Clin Oncol2015https://conductscience.org/library/papers/25559811PubMed
1738572751Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin2024https://conductscience.org/library/papers/38572751PubMed
1824707149Prognostic value of number of examined lymph nodes in patients with node-negative gastric cancer.World J Gastroenterol2014https://conductscience.org/library/papers/24707149PubMed
1921590318Clinicopathological analysis for recurrence of stage Ib gastric cancer (according to the second English edition of the Japanese classification of gastric carcinoma).Gastric Cancer2011https://conductscience.org/library/papers/21590318PubMed
2017978289Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine.N Engl J Med2007https://conductscience.org/library/papers/17978289PubMed

See all 38 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42978552

GET https://conductscience.org/api/papers/v1/42978552/references?page=2